These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22661988)

  • 1. Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.
    Yu B; Zhang B; Shi Y; Shao SH; Wang QW; Huang RP; Yang YQ
    Arch Med Sci; 2012 May; 8(2):183-91. PubMed ID: 22661988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
    Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
    Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
    Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profile of serum of pregnant women carring a fetus with Down syndrome using nano uplc Q-tof ms/ms technology.
    López Uriarte GA; Burciaga Flores CH; Torres de la Cruz VM; Medina Aguado MM; Gómez Puente VM; Romero Gutiérrez LN; Martínez de Villarreal LE
    J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1483-1489. PubMed ID: 28412848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome.
    Heywood WE; Madgett TE; Wang D; Wallington A; Hogg J; Mills K; Avent ND
    Proteome Sci; 2011 Sep; 9():56. PubMed ID: 21929753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of down syndrome biomarkers in maternal serum using isobaric tags for relative and absolute quantification (iTRAQ).
    Zhao SL; Liu XW; Wu SW; Zheng YY; Zhang WY
    Gynecol Endocrinol; 2020 Jun; 36(6):489-495. PubMed ID: 31793358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
    Lehavi O; Aizenstein O; Evans MI; Yaron Y
    Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
    Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
    Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic fluid and urine metabolomic alterations associated with pregnant women with Down syndrome fetuses.
    Chen X; Hu L; Su J; Liu X; Luo X; Pei Y; Gao Y; Wei F
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7882-7889. PubMed ID: 34130603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
    Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
    Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?
    Yu B; Kong J; Xing B; Zhu Z; Zhang B; Wang QW; Shao SH
    Neurol Sci; 2014 Apr; 35(4):589-93. PubMed ID: 24241822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing.
    Lim JH; Kang YJ; Lee BY; Han YJ; Chung JH; Kim MY; Kim MH; Kim JW; Cho YH; Ryu HM
    Clin Epigenetics; 2019 Dec; 11(1):180. PubMed ID: 31801612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential expression profile of miRNAs in amniotic fluid exosomes from fetuses with Down syndrome].
    Ding K; Yu L; Huang Z; Zheng H; Yang X; Tian T; Xie R
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):293-299. PubMed ID: 35365456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome.
    Tsangaris GT; Karamessinis P; Kolialexi A; Garbis SD; Antsaklis A; Mavrou A; Fountoulakis M
    Proteomics; 2006 Aug; 6(15):4410-9. PubMed ID: 16847874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma.
    Lee MJ; Na K; Jeong SK; Lim JS; Kim SA; Lee MJ; Song SY; Kim H; Hancock WS; Paik YK
    J Proteome Res; 2014 Nov; 13(11):4878-88. PubMed ID: 25057901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
    Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
    J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.